Global
computer aided detection market is expected to reach USD 1.9 billion by 2022,
according to a new report by Grand View Research Inc. CAD software tools have
been introduced to support radiologists to cope with the growing number of
images requiring interpretation. Increasing incidence rate of breast, prostate
and lung cancer, rising technological advancements, and increasing use of CAD
with other imaging modalities such as ultrasound and magnetic resonance imaging
are expected to serve this industry as high-impact rendering drivers.
In
the U.S., prostate cancer is one of the most common cancers amongst men and has
increased the demand for multi-parametric Magnetic Resonance Imaging (MP-MRI)
CADx systems for diagnosis and detection of prostate cancer.
In
screening mammography, the traditional concept of double reading by the second
clinician is expected to be replaced by CAD, of breast cancer completely. This
is due to the additional reimbursement generated by computer-aided detection
unlike the double readings that demand more of radiologists’ time without any
reimbursement for the second read.
Wide
research has been undertaken to come up with new findings establishing the
relation of cancer with anatomy. For instance, Johns Hopkins researchers established
the presence of dense clumps of bacteria in ascending colon to cancer.
CAD
is most widely used for breast cancer imaging due to a higher incidence of
cancer in women with morbidity of 14 million new cases and 8.2 deaths according
to the WHO 2012. With the increasing demand for imaging and the growing rate of
chronic diseases, the demand for imaging technologies is expected to increase.
Computer aided detection is now used with other imaging modalities such as
ultrasound, nuclear imaging, magnetic resonance imaging, etc.
In
2014, mammography dominated the industry as the prevalence of cancer is high
and is the leading cause of morbidity and mortality. According to the World
Cancer Research Fund International 2012, North America and Oceania have the highest
incidence rate of breast cancer and Asia and Africa has the lowest.
Digital
imaging technique advancements are the other contributing factors for market
growth as it has increased ease-of-integration of CAD solutions with imaging
equipment and has also improved the efficiency of computer aided detection
solutions.
In depth research report on Computer Aided Detection
(CAD) Market
Further key findings from the study suggest:
·
In 2014, mammography dominated
the market due to the fact that it has high potential for breast cancer imaging
and was one of the first segments in which companies developed CAD software and
till date most of it is working on this indication.
·
According to the WHO data 2012,
there were 14 million new cases of breast cancer. The increasing awareness has
led increase in regular cancer check-ups as a preventive step.
·
The demand for CAD has grown in
chest imaging such as low-dose lung cancer screening due to Multidetector
Computed Tomography (MDCT) indications. Furthermore, CAD has been brought in
use for established areas of chest CT such as diagnosis of interstitial lung
disease and acute Pulmonary Embolism (PE).
·
CAD is also used with other
imaging modalities such as x-ray, computed tomography, and ultrasound. Out of
these, the use of CAD for x-ray imaging is the highest as it is the basic
imaging and due to the recent advances overcoming its limitations of soft
tissue imaging.
·
North America was the most
revenue generating region of the market. The market contributed more than 40%
of the revenue in 2014. Constant efforts to fuel the market with newer
technologies and the use of computer aided detection for integrative diagnosis
apart from image analysis are expected to drive regional market growth over the
forecast period.
·
Asia Pacific and Europe are
expected to spearhead future market growth due to the availability of
cost-effective technologies and rise in medical tourism. UK cancer patients mostly
treat themselves in Eastern Europe, Germany, France, and Spain as these nations
specialize in cancer treatments, and as flights to these destinations are
relatively cheaper and consume lesser time.
·
Key market players are EDDA
Technology, Inc., FUJIFILM Medical Systems, Hitachi High Technologies
Corporation, Hologic Inc., iCAD, Inc., Vucomp, McKesson Corporation, Philips
Healthcare, Siemens Healthcare, and Toshiba Medical Systems Corporation.
Grand
View Research has segmented the global Computer Aided Detection (CAD) market on
the basis of application, breast CAD imaging modalities, imaging modalities,
and region:
Global Computer Aided Detection (CAD) Application
Outlook (Revenue, USD Million, 2012 - 2022)
·
Breast Cancer
·
Lung Cancer
·
Colon/ Rectal Cancer
·
Prostate Cancer
·
Liver Cancer
·
Bone Cancer
·
Neurological/ Musculoskeletal/
Cardiovascular
Global Breast CAD Imaging Modalities Outlook
(Revenue, USD Million, 2012 - 2022)
·
Mammography
·
Magnetic Resonance Imaging
·
Ultrasound Imaging
·
Tomosynthesis
·
Nuclear Imaging
·
Others
Global imaging modalities Outlook (Revenue, USD
Million, 2012 - 2022)
·
X-Ray Imaging
·
Computed Tomography
·
Ultrasound Imaging
·
Magnetic Resonance Imaging
·
Nuclear Medicine Imaging
·
Others
Computer Aided Detection (CAD) Regional Outlook
(Revenue, USD Million, 2012 - 2022)
·
North America
·
Europe
·
Asia Pacific
·
RoW
Browse more research reports of this category:
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment